α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra and the formation of aggregates (Lewy bodies) in neurons. alpha-Synuclein is the major protein in Lewy bodies and rare mutations in alpha-synuclein cause early-onset PD. Consequently, alpha-synuclein is implicated in the pathogenesis of PD. Here, we have investigated the degradation pathways of alpha-synuclein, using a stable inducible PC12 cell model, where the expression of exogenous human wild-type, A30P, or A53T alpha-synuclein can be switched on and off. We have used a panel of inhibitors/stimulators of autophagy and proteasome function and followed alpha-synuclein degradation in these cells. We found that not only is alpha-synuclein degraded by the proteasome, but it is also degraded by autophagy. A role for autophagy was further supported by the presence of alpha-synuclein in organelles with the ultrastructural features of autophagic vesicles. Since rapamycin, a stimulator of autophagy, increased clearance of alpha-synuclein, it merits consideration as a potential therapeutic for Parkinsons disease, as it is designed for chronic use in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, mutant forms of synuclein and oligomers are dependent on the autophagy–lysosome pathway for their clearance4–6.”
From Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice (2018) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies suggest that α-synuclein is degraded by macroautophagy, chaperone-mediated autophagy, and the proteasome20–23.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Macroautophagy is a key pathway for the clearance of aggregate-prone cytosolic proteins.”
From Lithium induces autophagy by inhibiting inositol monophosphatase (2005) · cites this paper as Webb et al., 2003
In the citing paper
“Early evidence suggested roles for CMA and macroautophagy in degrading SNCA/α‐synuclein (Webb et al, 2003; Cuervo et al, 2004).”
From Autophagy in major human diseases (2021) · cites this paper as Webb et al, 2003
In the citing paper
“We previously showed that EGFP-HDQ74 is cleared by autophagy.”
From Lithium induces autophagy by inhibiting inositol monophosphatase (2005) · cites this paper as Webb et al., 2003
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Greene, L. A., & Tischler, A. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.7.2424 · Cited by 5,553
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
Research works printed but not linked: 2
- Furlong, R. A., Narain, Y., Rankin, J., Wyttenbach, A., and Rubinsztein, D. C. (2000) Biochem. J. 346, 577-581 · DOI · Paper page
- Biederbick, A., Kern, H. F., and Elsasser, H. P. (1995) Eur. J. Cell Biol. 66, 3-14
Cited by
Items 701–800 of 1,001
Spreading of alpha‐synuclein – relevant or epiphenomenon?
Killinger, B. A., & Kordower, J. H. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14779 · Cited by 49
Protein Quality Control Pathways at the Crossroad of Synucleinopathies
de Mattos, E. P., Wentink, A. S., Nussbaum-Krammer, C. I., Hansen, C., Bergink, S., Melki, R., & Kampinga, H. H. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191790 · Cited by 47
“Data supporting a role for macroautophagy in the degradation of monomeric and pre-fibrillar Syn assemblies come mainly from studies detecting -Syn buildup upon exposure of cell lines overexpressing either WT or mutant -Syn variants to the inhibitor of autophagosome formation 3methyladenine [93, 95, 97, 131].”
BackgroundNascimento, A. C., Erustes, A. G., Reckziegel, P., Bincoletto, C., Ureshino, R. P., Pereira, G. J. S., & Smaili, S. S. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03126-8 · Cited by 52
Increase expression of α-synuclein in aged human brain associated with neuromelanin accumulation
Qi, X., Xu, S., Lu, D., Yu, S., Zhou, M., Uéda, K., Cui, Y., Zhang, B., & Chan, P. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0636-3 · Cited by 51
Cellular Responses to Protein Accumulation Involve Autophagy and Lysosomal Enzyme Activation
Butler, D., Brown, Q. B., Chin, D. J., Batey, L., Karim, S., Mutneja, M. S., Karanian, D. A., & Bahr, B. A. (2005) · Rejuvenation Research · doi:10.1089/rej.2005.8.227 · Cited by 46
Protective roles for induction of autophagy in multiple proteinopathies
Menzies, F. M., Ravikumar, B., & Rubinsztein, D. C. (2006) · Autophagy · doi:10.4161/auto.2696 · Cited by 45
Self-citationLim, S. W., Hyoung, B. J., Piao, S. G., Doh, K. C., Chung, B. H., & Yang, C. W. (2012) · Transplantation · doi:10.1097/tp.0b013e31825ace5c · Cited by 46
Ca2+, autophagy and protein degradation: Thrown off balance in neurodegenerative disease
Vicencio, J. M., Lavandero, S., & Szabadkai, G. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.013 · Cited by 47
Sala, G., Marinig, D., Riva, C., Arosio, A., Stefanoni, G., Brighina, L., Formenti, M., Alberghina, L., Colangelo, A. M., & Ferrarese, C. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.04.018 · Cited by 46
“Based on knowledge that macroautophagy participates, together with CMA, to alpha-synuclein degradation (Webb et al., 2003), through macroautophagy inhibition, we also explored the specific contribution of CMA in the accumulation of alpha-synuclein caused by rotenone, as previously demonstrated in…”
Pigna, E., Renzini, A., Greco, E. A., Simonazzi, E., Fulle, S., Mancinelli, R., Moresi, V., & Adamo, S. (2018) · Skeletal Muscle · doi:10.1186/s13395-018-0153-2 · Cited by 52
The Role of Autophagy in the Degradation of Misfolded HLA –B27 Heavy Chains
Navid, F., Layh‐Schmitt, G., Sikora, K. A., Cougnoux, A., & Colbert, R. A. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40414 · Cited by 44
Morozumi, S., Koike, H., Tomita, M., Kawagashira, Y., Iijima, M., Katsuno, M., Hattori, N., Tanaka, F., & Sobue, G. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182172290 · Cited by 44
Drobny, A., Boros, F. A., Balta, D., Huarcaya, S. P., Caylioglu, D., Qazi, N., Vandrey, J., Schneider, Y., Dobert, J. P., Pitcairn, C., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00363-z · Cited by 48
Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast
Popova, B., Kleinknecht, A., & Braus, G. (2015) · Biomolecules · doi:10.3390/biom5020617 · Cited by 42
“Consistently, the autophagy-activating drug rapamycin stimulates -synuclein clearance [115] and results in significantly reduced amounts of -synuclein inclusions [64].”
BackgroundSarkar, S. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.09.010 · Cited by 45
Proteasome inhibitor-induced autophagy in PC12 cells overexpressing A53T mutant α-synuclein
Lan, D.-M., Wang, W., Zhuang, J., & Zhao, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3011 · Cited by 46
“MG132‑induced α ‑syn accumulation. α -syn can be degraded by the UPS and ALP.”
InfluentialEndolysosomal dysfunction in Parkinson's disease: Recent developments and future challenges
Kett, L. R., & Dauer, W. T. (2016) · Movement Disorders · doi:10.1002/mds.26797 · Cited by 42
Perrino, G., Wilson, C., Santorelli, M., & di Bernardo, D. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.081 · Cited by 47
Melnik, B. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031059 · Cited by 46
Therapeutic Potential and Molecular Mechanisms of Echinacoside in Neurodegenerative Diseases
Li, J., Yu, H., Yang, C. H., Ma, T., & Dai, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.841110 · Cited by 51
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Brembati, V., Faustini, G., Longhena, F., & Bellucci, A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1197853 · Cited by 44
“Studies in cell models or purified systems led to conflicting results either supporting that both 20S and 26S proteasomes degrade α-Syn or failing to detect α-Syn accumulation upon UPS inhibition (Bennett et al., 1999; Tofaris et al., 2001, 2011; Webb et al., 2003; Emmanouilidou et al., 2010; Shabek et al., 2012) hint…”
ResultWu, G., Yan, B., Wang, X., Feng, X., Zhang, A., Xu, X., & Dong, H. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.04.011 · Cited by 45
Autophagy and Neurodegeneration
He, C., & Klionsky, D. J. (2006) · ACS Chemical Biology · doi:10.1021/cb600182h · Cited by 43
Kurzawa‐Akanbi, M., Tzoumas, N., Corral-Serrano, J. C., Guarascio, R., STEEL, D. H., Cheetham, M. E., Armstrong, L., & Lako, M. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101248 · Cited by 44
Crabtree, D., Dodson, M. B., Ouyang, X., Boyer‐Guittaut, M., Liang, Q., Ballestas, M. E., Fineberg, N. S., & Zhang, J. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12497 · Cited by 43
Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
Milisav, I., Šuput, D., & Ribarič, S. (2015) · Molecules · doi:10.3390/molecules201219865 · Cited by 43
“Clearance of aggregate prone forms of αSYN is mediated by MA [90]; pharmacological activation of MA by lithium or trehalose accelerates clearance of aggregate prone A30P and A53T mutants of αSYN [91].”
BackgroundWang, J., Han, X., Leu, N. A., Sterling, S., Kurosaka, S., Fina, M. E., Lee, V. M., Dong, D. W., Yates, J. R., & Kashina, A. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-11713-z · Cited by 49
Bekker, M., Abrahams, S., Loos, B., & Bardien, S. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.12.013 · Cited by 47
Exploring the Role of Autophagy Dysfunction in Neurodegenerative Disorders
Rana, T., Behl, T., Sehgal, A., Mehta, V., Singh, S., Bhatia, S., Al‐Harrasi, A., & BUNGAU, S. G. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02472-0 · Cited by 42
A randomized clinical trial of lithium in multiple system atrophy
Saccà, F., Marsili, A., Quarantelli, M., Morra, V. B., Brunetti, A., Carbone, R., Pane, C., Puorro, G., Russo, C. V., Salvatore, E., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6655-7 · Cited by 47
“It was recently demonstrated that lithium is able to stimulate autophagy, to remove protein aggregates [2] including alpha-synuclein [3], and to slow neurodegeneration and clinical progression in several animal models [4].”
BackgroundThe Benefits of Humanized Yeast Models to Study Parkinson’s Disease
Franssens, V., Bynens, T., den Brande, J. V., Vandermeeren, K., Verduyckt, M., & Winderickx, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/760629 · Cited by 45
“The observation in higher eukaryotes that α-synuclein aggregates can be removed by autophagy suggested a connection between autophagy and the pathogenesis of PD [33–35].”
BackgroundAlpha-synuclein and autophagy as common steps in neurodegeneration
Ferrucci, M., Pasquali, L., Ruggieri, S. A., Paparelli, A., & Fornai, F. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.025 · Cited by 44
PLK2 Modulates α-Synuclein Aggregation in Yeast and Mammalian Cells
Basso, E., Antas, P., Marijanovic, Z., Gonçalves, S. A., Tenreiro, S., & Outeiro, T. F. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8473-z · Cited by 41
“Interestingly, this pathway is also a known regulator of the autophagy degradation system that, together with the ubiquitin– proteasome system, is known to be responsible for the clearance of aSyn [33].”
BackgroundFive Questions (with their Answers) on ER ‐Associated Degradation
Pisoni, G. B., & Molinari, M. (2016) · Traffic · doi:10.1111/tra.12373 · Cited by 42
“Alternatively, if they cannot enter the proteasomal tunnel, or if they undergo aggregation, aberrant polypeptides are engulfed in autophagosomes that deliver them for autolysosomal destruction (Figure 5) (63).”
BackgroundHo, D. H., Seol, W., & Son, I. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1577666 · Cited by 39
“The degradation of αSyn is accomplished by both the ubiquitinproteasome and autophagy-lysosome pathways [35].”
BackgroundTamtaji, O. R., Taheri, M. N., Notghi, F., Alipoor, R., Bouzari, R., & Asemi, Z. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28654 · Cited by 44
Sepúlveda, D., Cisternas-Olmedo, M., Arcos, J., Nassif, M., & Vidal, R. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.805087 · Cited by 42
“Since Cav1 expression is upregulated in old rat brain and aged human cortex (Park et al., 2000; Kang et al., 2006), suggesting that overexpression of Cav-1 may induce aging phenotypes (Wheaton et al., 2001; Lee et al., 2015).”
BackgroundProtein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond
Agyemang, A. F., Harrison, S. R., Siegel, R. M., & McDermott, M. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0496-2 · Cited by 43
Quiescent fibroblasts are protected from proteasome inhibition–mediated toxicity
Legesse-Miller, A., Raitman, I., Haley, E. M., Liao, A., Sun, L., Wang, J., Krishnan, N., Lemons, J. M. S., Suh, E. J., Johnson, E. L., et al. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-03-0192 · Cited by 45
“Mice with a tissue-specific conditional knockout of autophagy components are deficient in the clearance of ubiquitinated protein aggregates, thereby indicating that although soluble ubiquitinated proteins can be cleared via the proteasome, aggregated, polyubiquitinated proteins are cleared by autophagy (Webb et al., 2…”
The Effect of Polyphenols on Protein Degradation Pathways: Implications for Neuroprotection
Hajieva, P. (2017) · Molecules · doi:10.3390/molecules22010159 · Cited by 43
“Autophagy is a key regulator of intracellular aggregation-prone proteins, as it is demonstrated in most prominent proteinopathies such as polyglutamine-expanded huntingtin in Huntington’s disease [15]; mutant TDP43 in amyotrophic lateral sclerosis [16]; mutant forms of α-synuclein in Parkinson’s disease [17]; and muta…”
BackgroundLian, X., Liu, Z., Gan, Z., Yan, Q., Tong, L., Qiu, L., Liu, Y., Chen, J., & Li, Z. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00764 · Cited by 44
“Multiple intracellular clearance pathways for α-synuclein exist not only in neurons but also in astrocytes and microglia, ranging from the ubiquitin-proteasome system (UPS) to two pathways within the autophagy-lysosome system (ALS) (Xilouri et al., 2016; Figure 2 ).”
InfluentialProtein kinase B/Akt1 inhibits autophagy by down-regulating UVRAG expression
Yang, W., Ju, J., Lee, K., Nam, K., Oh, S., & Shin, I. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.11.014 · Cited by 44
Hung, K.-C., Huang, H.-J., Lin, M., Lei, Y.-P., & Lin, A. M.-Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091074 · Cited by 40
Navarro-Yepes, J., Anandhan, A., Bradley, E., Bohovych, I., Yarabe, B., de Jong, A., Ovaa, H., Zhou, Y., Khalimonchuk, O., Quintanilla-Vega, B., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9414-9 · Cited by 37
Bogéa, T. H., Wen, R. H., & Moritz, O. L. (2015) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-16799 · Cited by 38
Kinarivala, N., Patel, R., Boustany, R., Al-Ahmad, A. J., & Trippier, P. C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01199 · Cited by 43
How autophagy can restore proteostasis defects in multiple diseases?
Joshi, V., Upadhyay, A., Prajapati, V. K., & Mishra, A. (2020) · Medicinal Research Reviews · doi:10.1002/med.21662 · Cited by 41
Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders
Deleidi, M., & Maetzler, W. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/391438 · Cited by 44
“In agreement with this observation, activation of autophagy leads to increased wild-type Asyn clearance and neuroprotection [37, 40].”
Chen, J.-F., & Schwarzschild, M. A. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.10.024 · Cited by 39
“It is postulated that A2A receptor activity may confer protection by control of ubiquitinproteasome system (UPS) and autolysosome activity associated with degradation of the accumulated α-synuclein [96,97].”
BackgroundCerebral sterile inflammation in neurodegenerative diseases
Otani, K., & Shichita, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00137-4 · Cited by 39
T cells, α-synuclein and Parkinson disease
Garretti, F., Monahan, C., Sette, A., Agalliu, D., & Sulzer, D. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00023-0 · Cited by 42
Hung, S., Huang, W., Liou, H., & Fu, W. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.003 · Cited by 40
α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies
Abdelkarim, H., Marshall, M. S., Scesa, G., Smith, R. A., Rue, E. A., Marshall, J. N., Elackattu, V., Stoskute, M., Issa, Y., Santos, M. B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30808-9 · Cited by 41
Neurological effects of glucocerebrosidase gene mutations
Mullin, S., Hughes, D. A., Mehta, A. B., & Schapira, A. H. V. (2018) · European Journal of Neurology · doi:10.1111/ene.13837 · Cited by 40
Adams, J., Feuerborn, M., Molina, J. A., Wilden, A. R., Adhikari, B., Budden, T., & Lee, S. Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-36379-z · Cited by 38
A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body–like pathology
Gerez, J., Prymaczok, N. C., Rockenstein, E. M., Herrmann, U., Schwarz, P., Adame, A., Enchev, R. I., Courthéoux, T., Boersema, P. J., Riek, R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6722 · Cited by 41
SUMOylation in α-Synuclein Homeostasis and Pathology
Savyon, M., & Engelender, S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00167 · Cited by 40
“…molecules, specifically at lysines 12, 21 and 23 (Hasegawa et al., 2002; Tofaris et al., 2003; Anderson et al., 2006). α-synuclein is degraded by the proteasome in cell lines and mice brain tissues (Bennett et al., 1999; Webb et al., 2003; Ebrahimi-Fakhari et al., 2011; Rott et al., 2011).”
BackgroundMechanisms of neuronal survival safeguarded by endocytosis and autophagy
Overhoff, M., Bruyckere, E. D., & Kononenko, N. L. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15194 · Cited by 46
“Notably, several studies identified that α-Synuclein is degraded via autophagy, including the CMA (Vogiatzi et al., 2008; Webb et al., 2003), and that increased levels of α-Synuclein mediated by the gene duplication in PD can cause mislocalization of ATG9 and compromise autophagy (Winslow et al.,…”
BackgroundIdentification of BAG2 and Cathepsin D as Plasma Biomarkers for Parkinson’s Disease
Kang, J., Kim, J. W., Heo, H., Lee, J., Park, K. Y., Yoon, J. H., & Chang, J. (2020) · Clinical and Translational Science · doi:10.1111/cts.12920 · Cited by 40
Jiang, P., Gan, M., Lin, W.-L., & Yen, S.-H. C. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00268 · Cited by 43
The Transcellular Propagation and Intracellular Trafficking of α-Synuclein
Tofaris, G. K., Goedert, M., & Spillantini, M. G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024380 · Cited by 41
Hunn, B. H. M., Vingill, S., Threlfell, S., Alegre-Abarrategui, J., Magdelyns, M., Deltheil, T., Bengoa-Vergniory, N., Oliver, P. L., Cioroch, M., Doig, N. M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.029 · Cited by 38
Esteves, A. R., Silva, D. F., Banha, D., Candeias, E., Guedes, B., & Cardoso, S. M. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102714 · Cited by 39
“a-Syn accumulation is a hallmark of PD neuropathology and is a known autophagic substrate [52].”
BackgroundYue, Y., Zhang, X., Lv, W., Lai, H., & Shen, T. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.390970 · Cited by 39
“…is mounting evidence linking synucleinopathies to the clearance system; alongside the autophagy lysosomal pathway and ubiquitin proteasome system (Webb et al., 2003), the glymphatic system is also believed to play a role in the clearance of α-synuclein (Nakamura et al., 2016; Hoshi et al., 2017).”
BackgroundSleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night
Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Elewa, Y. H. A., AL-Farga, A. M., Aqlan, F. M., Zahran, M. H., & Batiha, G. E. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14521 · Cited by 41
“A previous study conducted by Webb et al. 197 revealed that α - Syn is degraded by proteasomes and autophagy.”
BackgroundMethodRissardo, J. P., McGarry, A. J., Shi, Y., Caprara, A. L. F., & Kannarkat, G. T. (2025) · Brain Sciences · doi:10.3390/brainsci15121260 · Cited by 44
“α Syn is degraded by both autophagy and the proteasome mechanisms [110]. α Syn aggregates inhibit autophagy, leading to accumulation of toxic proteins and damaged organelles, which can be observed by the impairment of SNAP29 (synaptosome-associated protein 29) function [111]. α Syn may impair the…”
Quality Control Compartments Coming of Age
Ben‐Gedalya, T., & Cohen, E. (2012) · Traffic · doi:10.1111/j.1600-0854.2012.01330.x · Cited by 40
Li, T., Yang, F., Yang, R., Wu, L., Li, R., Huang, L. H., Yang, Q., & Chen, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00377 · Cited by 40
“The ALP is primarily responsible for the bulk degradation of redundant cellular materials under various stress conditions, including longer-lived macromolecules and damaged organelles (Klionsky, 2007; He and Klionsky, 2009).”
BackgroundInfluentialMetabolic aspects of neuronal degeneration: From a NAD+ point of view
Sasaki, Y. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.07.001 · Cited by 39
The role of lipids in autophagy and its implication in neurodegeneration
Hernández-Díaz, S., & Soukup, S. (2020) · Cell Stress · doi:10.15698/cst2020.07.225 · Cited by 42
“For instance, macroautophagy reduces the toxic level of aggregates caused by the accumulation of mutant huntingtin, α-synuclein and tau in vitro as well as in vivo Drosophila and mouse disease models [150, 153, 156, 157].”
BackgroundExtracellular alpha-synuclein: Sensors, receptors, and responses
Domingues, R., Sant’Anna, R., da Fonseca, A. C. C., Robbs, B. K., Foguel, D., & Outeiro, T. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105696 · Cited by 41
“ALP dysfunctions have been implicated in the accumulation of aSyn aggregates leading to their release and uptake by adjacent cells, in a R. Domingues et al. Neurobiology of Disease 168 (2022) 105696 prion-like cycle of propagation (Sacino et al., 2017; Steiner et al., 2011; Jang et al., 2010; Bae et al., 2015).”
BackgroundInfluentialZhou, H., Shao, M., Guo, B., Li, C., Lu, Y., Yang, X., Shengnan, L., Li, H., Zhu, Q., Zhong, H., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00759-8 · Cited by 37
“To investigate the potential ability of T-006 in PD, the previously characterized inducible PC12 stable cell lines overexpressing α-syn (WT, A30P, A53T) [23] were maintained in 150 μg/ml hygromycin B in DMEM supplemented with 10%HS, 5% FBS, 100 units/mL penicillin/streptomycin, and 50 μg/ml G418 in a humidified atmosp…”
InfluentialBortolozzi, A., Manashirov, S., Chen, A., & Artigas, F. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107873 · Cited by 37
Ambiguous Effects of Autophagy Activation Following Hypoperfusion/Ischemia
Ferrucci, M., Biagioni, F., Ryskalin, L., Limanaqi, F., Gambardella, S., Frati, A., & Fornai, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092756 · Cited by 37
Autophagy Stimulation Decreases Dopaminergic Neuronal Death Mediated by Oxidative Stress
Ramirez-Moreno, M. J., Duarte-Jurado, A. P., Gopar‐Cuevas, Y., González-Alcocer, A., Loera‐Arias, M. D. J., Cárdenas, O. S., Montes‐de‐Oca‐Luna, R., Rodríguez‐Rocha, H., & García‐García, A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01654-1 · Cited by 39
Krishnan, S., Shrestha, Y., Jayatunga, D. P. W., Rea, S. L., Martins, R. N., & Bharadwaj, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186739 · Cited by 42
“However, non-ATP-competitive inhibitors like rapamycin and its analogues have shown benefits as autophagy inducers in animal models of AD, Parkinson’s disease (PD), Huntington’s disease (HD) and prion protein (PrP) disease [127,133,139–142].”
BackgroundFrom Lysosomal Storage Disorders to Parkinson’s Disease – Challenges and Opportunities
Mächtel, R., Boros, F. A., Dobert, J. P., Arnold, P., & Zunke, F. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167932 · Cited by 39
Olson, K. E., Abdelmoaty, M. M., Namminga, K. L., Lu, Y., Obaro, H., Santamaria, P. M., Mosley, R. L., & Gendelman, H. E. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00361-1 · Cited by 40
“Autophagy was a focus in this study as it represents a principal intracellular proteolytic process for clearance of α-syn aggregates [37].”
BackgroundSynphilin-1 inhibits alpha-synuclein degradation by the proteasome
Alvarez‐Castelao, B., & Castaño, J. G. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0592-3 · Cited by 37
“degraded by the 20S proteasome [33–35] and may also participate in alpha-synuclein degradation in situ [36, 37].”
BackgroundHeat Stroke Induces Autophagy as a Protection Mechanism Against Neurodegeneration in the Brain
Liu, T., Hu, C.-H., Tsai, C.-D., Li, C.-W., Lin, Y., & Wang, J. (2010) · Shock · doi:10.1097/shk.0b013e3181e761c1 · Cited by 37
Dysregulation of autophagy and Parkinson’s disease: the MEF2D link
Yang, Q., & Mao, Z. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0475-y · Cited by 37
“This includes evidence demonstrating that both macroautophagy and CMA regulate a-synuclein [13, 14].”
Backgroundvan der Vlag, M., Havekes, R., & Heckman, P. R. A. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14689 · Cited by 38
α-Synuclein Stimulates Differentiation of Osteosarcoma Cells
Fujita, M., Sugama, S., Nakai, M., Takenouchi, T., Wei, J., Urano, T., Inoue, S., & Hashimoto, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606175200 · Cited by 40
Zenko, D., Marsh, J., Castle, A. R., Lewin, R., Fischer, R., & Tofaris, G. K. (2023) · Science Advances · doi:10.1126/sciadv.add8910 · Cited by 39
Wei, P., Jin, P., Barui, A. K., Hu, Y. B., Zhang, L., Zhang, J., Shi, S.-S., Zhang, H., Lin, J., Zhou, W., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.09.006 · Cited by 37
“[72] Additionally, earlier literatures[15] have demonstrated that trehalose-activated autophagy enhances the clearance of misfolded proteins linked with neurodegenerative disorders such as A30P and A53T mutants of α-synuclein, associated with Parkinson disease (PD) to protect cells against cell death.”
BackgroundYeast buddies helping to unravel the complexity of neurodegenerative disorders
Fruhmann, G., Seynnaeve, D., Zheng, J., Ven, K., Molenberghs, S., Wilms, T., Liu, B., Winderickx, J., & Franssens, V. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.05.002 · Cited by 40
Role of the VPS35 D620N mutation in Parkinson's disease
Mohan, M., & Mellick, G. D. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.12.001 · Cited by 40
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 37
Autophagy in α-Synucleinopathies—An Overstrained System
Fellner, L., Gabassi, E., Haybaeck, J., & Edenhofer, F. (2021) · Cells · doi:10.3390/cells10113143 · Cited by 45
Fox, S. N., McMeekin, L. J., Savage, C. H., Joyce, K. L., Boas, S. M., Simmons, M. S., Farmer, C. B., Ryan, J., Pereboeva, L., Becker, K., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00369-w · Cited by 41
Inhibition of glucosylceramide synthase stimulates autophagy flux in neurons
Shen, W., Henry, A. G., Paumier, K. L., Li, L., Mou, K., Dunlop, J., Berger, Z., & Hirst, W. D. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12672 · Cited by 41
Genetic analysis of the LAMP-2 gene promoter in patients with sporadic Parkinson's disease
Pang, S., Chen, D., Zhang, A., Qin, X., & Yan, B. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.07.044 · Cited by 38
Chhangani, D., Upadhyay, A., Amanullah, A., Joshi, V., & Mishra, A. (2014) · Scientific Reports · doi:10.1038/srep05077 · Cited by 38
Induction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene
Ying, H., Turturro, S. B., Nguyen, T., Shen, X., Zelkha, R., Johnson, E. C., Morrison, J. C., & Yue, B. Y. (2015) · BMC Cell Biology · doi:10.1186/s12860-015-0060-x · Cited by 37
“Rapamycin, lithium, and trehalose have also been shown to increase clearance of autophagy substrates α-synuclein and mutant huntingtin [65,66].”
Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo
Svarcbahs, R., Julku, U. H., Norrbacka, S., & Myöhänen, T. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-19823-y · Cited by 38
Advances in the genetics of Parkinson's disease
Rosner, S., Giladi, N., & Orr‐Urtreger, A. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00731.x · Cited by 39
Hua, J., Yin, N., Xu, S., Chen, Q., Tao, T., Zhang, J., Ding, J., Fan, Y., & Hu, G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00696-2 · Cited by 39
Upregulated pexophagy limits the capacity of selective autophagy
Germain, K., So, R. W. L., DiGiovanni, L. F., Watts, J. C., Bandsma, R., & Kim, P. K. (2024) · Nature Communications · doi:10.1038/s41467-023-44005-4 · Cited by 40
“5b), supporting their autophagic degradation as previously reported 30,31 .”
MicroRNAs: Game Changers in the Regulation ofα-Synuclein in Parkinson’s Disease
Zhao, L., & Wang, Z. (2019) · Parkinson s Disease · doi:10.1155/2019/1743183 · Cited by 46
“,e autophagy-lysosome network (ALN) is another pathway that degrades α-syn under physiological conditions [22, 78, 79].”
BackgroundDahmene, M., Bérard, M., & Oueslati, A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.759373 · Cited by 37
Metadata
- Authors
- Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C.
- Affiliations
- Addenbrooke's Hospital (GB)
- University of Cambridge (GB)
- Corresponding author
- Rubinsztein, David C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-07
- Volume
- 278
- Issue
- 27
- Pages
- 25009-25013
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2157535220
- Cited by
- 1,429
- References
- 37
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 76 · 2023: 50 · 2022: 68 · 2021: 71 · 2020: 83 · 2019: 85 · 2018: 77 · 2017: 62 · 2016: 65 · 2015: 65 · 2014: 75 · 2013: 79 · 2012: 95
- FWCI
- 18.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6305 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Parkinson's UK
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- alpha-synuclein, Parkinson's disease, autophagy, proteasome, protein degradation, Lewy bodies, A30P mutation, A53T mutation, PC12 cells, rapamycin, autophagic vesicles, dopaminergic neurons
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Autophagy, Cysteine Endopeptidases, Humans, Multienzyme Complexes, Nerve Tissue Proteins, PC12 Cells, Sirolimus, Proteasome Endopeptidase Complex, Rats, Synucleins, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.